SMFL - HRTX MESO and POET are among premarket gainers
2024-04-23 08:48:50 ET
More on premarket gainers & stock
- Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
- Mesoblast Limited: Back From The Dead
- Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Mesoblast gains as FDA backs regulatory plans for cell therapy
- Heron Therapeutics Q4 2023 Earnings Preview